Tarsus Pharmaceuticals TARS
NASDAQ TARS
$75.46 -3.15 (-4.01%)
At close: Oct 1, 2026 · 4:00 PM EDT

Tarsus Pharmaceuticals (TARS) Other Operating Expenses (2021 - 2026)

Updated

Tarsus Pharmaceuticals (TARS) posted Other Operating Expenses of $12.11 million for Q2 2026, up 94.2% from $6.24 million a year earlier and up 28.9% from the prior quarter.

Analysis

Tarsus Pharmaceuticals (TARS) Other Operating Expenses (2021 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Other Operating Expenses at Tarsus Pharmaceuticals was $40.75 million, up 107.7% year-over-year; for FY2025, it came in at $30.68 million, up 139.2% from FY2024.

  • Annual Other Operating Expenses has increased for three consecutive years, with a four-year compound annual growth rate of 96.1% (FY2021 to FY2025).
  • In prior years, Tarsus Pharmaceuticals' Other Operating Expenses was $12.83 million in FY2024 (+705.1%), $1.59 million in FY2023 (+66.8%), $955,000 in FY2022 (-54.0%) and $2.08 million in FY2021.
  • The Q2 2026 figure stands as the highest quarterly Other Operating Expenses in data going back to Q1 2021.
  • On a year-over-year basis, Other Operating Expenses has increased in each of the last eight quarters, with growth averaging 230.0% over the last eight quarters.
  • The strongest year-over-year quarter for Other Operating Expenses in the past five years was Q3 2024, with growth of 759.9%; the weakest was Q1 2022, with a decline of 97.5%.
  • According to Business Quant data, Other Operating Expenses for the three prior quarters was $9.4 million (Q1 2026), $10.93 million (Q4 2025) and $8.31 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Tarsus Pharmaceuticals 3.40 Bn 2.35 Bn 161.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.11 Mn
Mar 31, 2026 9.40 Mn
Dec 31, 2025 10.93 Mn
Sep 30, 2025 8.31 Mn
Jun 30, 2025 6.24 Mn
Mar 31, 2025 5.21 Mn
Dec 31, 2024 4.93 Mn
Sep 30, 2024 3.24 Mn
Jun 30, 2024 3.00 Mn
Mar 31, 2024 1.65 Mn
Dec 31, 2023 1.22 Mn
Sep 30, 2023 377,000.00
Dec 31, 2022 400,000.00
Jun 30, 2022 522,000.00
Mar 31, 2022 33,000.00
Dec 31, 2021 -24,000.00
Sep 30, 2021 65,000.00
Jun 30, 2021 737,000.00
Mar 31, 2021 1.30 Mn
API Access

Tarsus Pharmaceuticals Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=TARS&period=max&api_key=YOUR_API_KEY